Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
This study has been terminated.
( Study was terminated due to slow subject accrual )
Study NCT00592007   Information provided by University of California, San Diego

First Received on December 26, 2007.   Last Updated on July 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial